The Pitt’s commanding 93.5% market-implied odds reflect its status as the clear frontrunner after earning a leading 25 Emmy nominations for season 2, nearly doubling its prior haul and outpacing every other drama contender. The HBO Max medical series built on last year’s surprise win with expanded acting, writing, and directing recognition, strong reviews for its real-time format and Noah Wyle’s lead performance, and broad industry support. With final-round voting now closed ahead of the September 14 ceremony, traders see little room for a reversal. An upset would require voters to favor Apple TV+ newcomer Pluribus despite its fewer nods, or for late momentum to shift toward established nominees like Slow Horses or The Diplomat—scenarios viewed as unlikely given The Pitt’s precursor dominance and nomination breadth.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedEmmys 2026: Outstanding drama series
“The Pitt” 94%
“A Knight of the Seven Kingdoms” 2.1%
“Slow Horses” 1.9%
“Your Friends & Neighbors” 1.8%
$26,190 Vol.
$26,190 Vol.
“The Pitt”
94%
“A Knight of the Seven Kingdoms”
2%
“Slow Horses”
2%
“Your Friends & Neighbors”
2%
“The Gilded Age”
2%
"The Diplomat"
2%
“Paradise”
1%
“The Pitt” 94%
“A Knight of the Seven Kingdoms” 2.1%
“Slow Horses” 1.9%
“Your Friends & Neighbors” 1.8%
$26,190 Vol.
$26,190 Vol.
“The Pitt”
94%
“A Knight of the Seven Kingdoms”
2%
“Slow Horses”
2%
“Your Friends & Neighbors”
2%
“The Gilded Age”
2%
"The Diplomat"
2%
“Paradise”
1%
This market will resolve according to the nominee who wins the 2026 Emmy award for “Outstanding drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Market Opened: Jul 10, 2026, 10:18 AM ET
Resolver
0x69c47De9D...This market will resolve according to the nominee who wins the 2026 Emmy award for “Outstanding drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Resolver
0x69c47De9D...The Pitt’s commanding 93.5% market-implied odds reflect its status as the clear frontrunner after earning a leading 25 Emmy nominations for season 2, nearly doubling its prior haul and outpacing every other drama contender. The HBO Max medical series built on last year’s surprise win with expanded acting, writing, and directing recognition, strong reviews for its real-time format and Noah Wyle’s lead performance, and broad industry support. With final-round voting now closed ahead of the September 14 ceremony, traders see little room for a reversal. An upset would require voters to favor Apple TV+ newcomer Pluribus despite its fewer nods, or for late momentum to shift toward established nominees like Slow Horses or The Diplomat—scenarios viewed as unlikely given The Pitt’s precursor dominance and nomination breadth.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions